Article
Physical Activity Improves Outcomes of Combined Lenvatinib Plus Anti-PD-1 Therapy In Patients With Unresectable Hepatocellular Carcinoma
2021-11-19
Abstract excerpt
<title>Abstract</title> <p><bold>Background: </bold>Adaptive resistance is one of the major hinderances for unresectable hepatocellular carcinoma (HCC)<bold> </bold>treated<bold> </bold>with lenvatinib and<bold> </bold>anti-programmed cell death protein 1 (anti-PD-1) therapy. Physical activity is known to have anti-cancer effects, including immunomodulatory actions, influencing patients’ outcomes. This study inve...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- 503a44f2-8d21-5ffb-8f8f-29be3a95a432
- DOI
- 10.21203/rs.3.rs-1078571/v1
